Pfizer's $1.97 Billion Surge Propels It to 37th in Market Activity Amid 3.98% Plunge as Investors Eye Drug Trial Uncertainty

, 2025, . Despite the surge in liquidity, , signaling heightened investor caution ahead of key upcoming events in its drug development pipeline.

The pharmaceutical giant faces mounting pressure as recent clinical trial updates for its experimental Alzheimer’s drug remain under regulatory scrutiny. Analysts note that while the company’s oncology portfolio continues to drive long-term growth, near-term volatility is likely to persist amid mixed market sentiment toward high-risk therapeutic innovations.

Investor positioning appears divided between those capitalizing on short-term dips in the stock and those hedging against potential setbacks in its late-stage trials. The unusually high trading volume suggests increased institutional activity, though the directionality of these trades remains unclear without further disclosure from major stakeholders.

To deliver a meaningful back-test result I need to pin down a few implementation details, because “buy the top 500 stocks by daily trading volume” is a cross-sectional portfolio strategy (many tickers each day). Our back-testing engine can certainly handle it, but I have to define precise trading rules and the universe before retrieving data.

Could you please confirm the following settings (or adjust them)? 1. Universe • US common stocks (NYSE + NASDAQ + AMEX) • Exclude ETFs and OTC issues (If you prefer another universe, let me know.) 2. Ranking & rebalance frequency • Each trading day we rank the whole universe by that day’s dollar trading volume (close price × shares traded). • Go long the top 500 names. 3. Execution price & holding period • Enter at the next day’s open and exit at that day’s close (i.e., hold exactly one trading day). • Positions are equally weighted across the 500 names. 4. Transaction costs • Assume zero unless you specify otherwise. 5. . Once you confirm (or modify) these assumptions I’ll start the automated data retrieval and back-test.